Insulin Stimulates S100B Secretion and These Proteins Antagonistically Modulate Brain Glucose Metabolism

Neurochemical Research

Volumn 41, Issue 6, 2016, Pages 1420-1429

  Wartchow, Krista Minéia ^a   Tramontina, Ana Carolina ^b   de Souza, Daniela F ^a   Biasibetti, Regina ^a   Bobermin, Larissa D ^a   Gonçalves, Carlos Alberto ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE ESTADUAL DO RIO GRANDE DO SUL   (Brazil)

Author keywords

Astrocyte; Glucose metabolism; Insulin; MAPK; RAGE; S100B

Indexed keywords

GLUCOSE; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN S100B; S100B PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE CULTURE; CEREBROSPINAL FLUID LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GLIOMA CELL; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HIPPOCAMPAL SLICE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SECRETION; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; ASTROCYTE; CELL CULTURE; DOSE RESPONSE; DRUG EFFECTS; HIPPOCAMPUS; METABOLISM; ORGAN CULTURE TECHNIQUE; SECRETION (PROCESS); WISTAR RAT;

ANIMALS; ASTROCYTES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; HIPPOCAMPUS; INSULIN; MALE; ORGAN CULTURE TECHNIQUES; RATS; RATS, WISTAR; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT;

EID: 84957968408     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-016-1851-y     Document Type: Article

References (49)

1. Belanger M, Magistretti PJ (2009) The role of astroglia in neuroprotection. Dialogues Clin Neurosci 11:281–295
2. Pellerin L, Magistretti PJ (2004) Neuroenergetics: calling upon astrocytes to satisfy hungry neurons. Neurosci Rev J Bring Neurobiol Neurol Psychiatry 10:53–62. doi:10.1177/1073858403260159
3. Pellerin L (2008) Brain energetics (thought needs food). Curr Opin Clin Nutr Metab Care 11:701–705. doi:10.1097/MCO.0b013e328312c368
4. Banks WA, Owen JB, Erickson MA (2012) Insulin in the brain: there and back again. Pharmacol Ther 136:82–93. doi:10.1016/j.pharmthera.2012.07.006
5. Gerozissis K (2004) Brain insulin and feeding: a bi-directional communication. Eur J Pharmacol 490:59–70. doi:10.1016/j.ejphar.2004.02.044
6. Unger JW, Moss AM, Livingston JN (1991) Immunohistochemical localization of insulin receptors and phosphotyrosine in the brainstem of the adult rat. Neuroscience 42:853–861
7. Duarte AI, Moreira PI, Oliveira CR (2012) Insulin in central nervous system: more than just a peripheral hormone. J Aging Res 2012:384017. doi:10.1155/2012/384017
8. Chen Z, Zhong C (2013) Decoding Alzheimer’s disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog Neurobiol 108:21–43. doi:10.1016/j.pneurobio.2013.06.004
9. De la Monte SM (2012) Brain insulin resistance and deficiency as therapeutic targets in Alzheimer’s disease. Curr Alzheimer Res 9:35–66
10. Steiner J, Bernstein H-G, Bogerts B et al (2008) S100B is expressed in, and released from, OLN-93 oligodendrocytes: influence of serum and glucose deprivation. Neuroscience 154:496–503. doi:10.1016/j.neuroscience.2008.03.060
11. Donato R (2003) Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 60:540–551. doi:10.1002/jemt.10296
12. Donato R, Sorci G, Riuzzi F et al (2009) S100B’s double life: intracellular regulator and extracellular signal. Biochim Biophys Acta 1793:1008–1022. doi:10.1016/j.bbamcr.2008.11.009
13. Donato R, Cannon BR, Sorci G et al (2013) Functions of S100 proteins. Curr Mol Med 13:24–57
14. Frizzo JK, Tramontina F, Bortoli E et al (2004) S100B-mediated inhibition of the phosphorylation of GFAP is prevented by TRTK-12. Neurochem Res 29:735–740
15. Landar A, Caddell G, Chessher J, Zimmer DB (1996) Identification of an S100A1/S100B target protein: phosphoglucomutase. Cell Calcium 20:279–285
16. Zimmer DB, Van Eldik LJ (1986) Identification of a molecular target for the calcium-modulated protein S100. Fructose-1,6-bisphosphate aldolase. J Biol Chem 261:11424–11428
17. Gonçalves C-A, Leite MC, Nardin P (2008) Biological and methodological features of the measurement of S100B, a putative marker of brain injury. Clin Biochem 41:755–763. doi:10.1016/j.clinbiochem.2008.04.003
18. Kleindienst A, Hesse F, Bullock MR, Buchfelder M (2007) The neurotrophic protein S100B: value as a marker of brain damage and possible therapeutic implications. Prog Brain Res 161:317–325. doi:10.1016/S0079-6123(06)61022-4
19. Rojas A, Delgado-López F, González I et al (2013) The receptor for advanced glycation end-products: a complex signaling scenario for a promiscuous receptor. Cell Signal 25:609–614. doi:10.1016/j.cellsig.2012.11.022
20. Biasibetti R, Tramontina AC, Costa AP et al (2013) Green tea (−)epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia. Behav Brain Res 236:186–193. doi:10.1016/j.bbr.2012.08.039
21. Vizuete AF, de Souza DF, Guerra MC et al (2013) Brain changes in BDNF and S100B induced by ketogenic diets in Wistar rats. Life Sci 92:923–928. doi:10.1016/j.lfs.2013.03.004
22. Gonçalves CA, Leite MC, Guerra MC (2010) Adipocytes as an important source of serum S100B and possible roles of this protein in adipose tissue. Cardiovasc Psychiatry Neurol 2010:790431. doi:10.1155/2010/790431
23. Suzuki F, Kato K (1985) Inhibition of adipose S-100 protein release by insulin. Biochim Biophys Acta 845:311–316
24. Steiner J, Bernstein H-G, Schiltz K et al (2014) Decrease of serum S100B during an oral glucose tolerance test correlates inversely with the insulin response. Psychoneuroendocrinology 39:33–38. doi:10.1016/j.psyneuen.2013.10.001
25. Bobermin LD, Quincozes-Santos A, Guerra MC et al (2012) Resveratrol prevents ammonia toxicity in astroglial cells. PLoS One 7:e52164. doi:10.1371/journal.pone.0052164
26. De Souza DF, Leite MC, Quincozes-Santos A et al (2009) S100B secretion is stimulated by IL-1beta in glial cultures and hippocampal slices of rats: likely involvement of MAPK pathway. J Neuroimmunol 206:52–57. doi:10.1016/j.jneuroim.2008.10.012
27. Tramontina AC, Nardin P, Quincozes-Santos A et al (2012) High-glucose and S100B stimulate glutamate uptake in C6 glioma cells. Neurochem Res 37:1399–1408. doi:10.1007/s11064-012-0722-4
28. Nardin P, Tortorelli L, Quincozes-Santos A et al (2009) S100B secretion in acute brain slices: modulation by extracellular levels of Ca(2+) and K(+). Neurochem Res 34:1603–1611. doi:10.1007/s11064-009-9949-0
29. Zanotto C, Abib RT, Batassini C et al (2013) Non-specific inhibitors of aquaporin-4 stimulate S100B secretion in acute hippocampal slices of rats. Brain Res 1491:14–22. doi:10.1016/j.brainres.2012.10.065
30. Pellerin L, Magistretti PJ (1994) Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A 91:10625–10629
31. Peterson GLA et al (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83:346–356
32. Rodrigues L, Biasibetti R, Swarowsky A et al (2009) Hippocampal alterations in rats submitted to streptozotocin-induced dementia model are prevented by aminoguanidine. J Alzheimers Dis JAD 17:193–202. doi:10.3233/JAD-2009-1034
33. Tramontina AC, Wartchow KM, Rodrigues L et al (2011) The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer’s disease in rats. J Neural Transm Vienna Austria 118:1641–1649. doi:10.1007/s00702-011-0680-z
34. Baber Z, Haghighat N (2010) Glutamine synthetase gene expression and glutamate transporters in C6-glioma cells. Metab Brain Dis 25:413–418. doi:10.1007/s11011-010-9223-9
35. Quincozes-Santos A, Bobermin LD, Souza DG et al (2014) Guanosine protects C6 astroglial cells against azide-induced oxidative damage: a putative role of heme oxygenase 1. J Neurochem 130:61–74. doi:10.1111/jnc.12694
36. Esposito E, Iacono A, Muià C et al (2008) Signal transduction pathways involved in protective effects of melatonin in C6 glioma cells. J Pineal Res 44:78–87. doi:10.1111/j.1600-079X.2007.00492.x
37. Nardin P, Tramontina F, Leite MC et al (2007) S100B content and secretion decrease in astrocytes cultured in high-glucose medium. Neurochem Int 50:774–782. doi:10.1016/j.neuint.2007.01.013
38. Leite MC, Galland F, de Souza DF et al (2009) Gap junction inhibitors modulate S100B secretion in astrocyte cultures and acute hippocampal slices. J Neurosci Res 87:2439–2446. doi:10.1002/jnr.22083
39. Gonçalves CA, Gottfried C, Dunkley PR (2000) The use of permeabilized cells to assay protein phosphorylation and catecholamine release. Neurochem Res 25:885–894
40. Salkovic-Petrisic M, Hoyer S (2007) Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. J Neural Transm Suppl 72:217–233
41. Ziegler DR, Oliveira DL, Pires C et al (2004) Ketogenic diet fed rats have low levels of S100B in cerebrospinal fluid. Neurosci Res 50:375–379. doi:10.1016/j.neures.2004.07.013
42. Deng C (2013) Effects of antipsychotic medications on appetite, weight, and insulin resistance. Endocrinol Metab Clin N Am 42:545–563. doi:10.1016/j.ecl.2013.05.006
43. De Souza DF, Wartchow K, Hansen F et al (2013) Interleukin-6-induced S100B secretion is inhibited by haloperidol and risperidone. Prog Neuropsychopharmacol Biol Psychiatry 43:14–22. doi:10.1016/j.pnpbp.2012.12.001
44. Steiner J, Walter M, Guest P et al (2010) Elevated S100B levels in schizophrenia are associated with insulin resistance. Mol Psychiatry 15:3–4. doi:10.1038/mp.2009.87
45. Tramontina AC, Tramontina F, Bobermin LD et al (2008) Secretion of S100B, an astrocyte-derived neurotrophic protein, is stimulated by fluoxetine via a mechanism independent of serotonin. Prog Neuropsychopharmacol Biol Psychiatry 32:1580–1583. doi:10.1016/j.pnpbp.2008.06.001
46. McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH (2006) The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Expert Opin Drug Saf 5:157–168. doi:10.1517/14740338.5.1.157
47. Monden M, Koyama H, Otsuka Y et al (2013) Receptor for advanced glycation end products regulates adipocyte hypertrophy and insulin sensitivity in mice: involvement of Toll-like receptor 2. Diabetes 62:478–489. doi:10.2337/db11-1116
48. Leclerc E, Sturchler E, Vetter SW (2010) The S100B/RAGE axis in Alzheimer’s disease. Cardiovasc Psychiatry Neurol 2010:539581. doi:10.1155/2010/539581
49. Correia SC, Santos RX, Carvalho C et al (2012) Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer’s disease and diabetes interrelation. Brain Res 1441:64–78. doi:10.1016/j.brainres.2011.12.063